Indivior
INDV
36.13
+0.23
+0.64%
Indivior
US · INDV
#2252 by market cap
Listed 1970
36.13
+0.23
+0.64%
Live - 5344 symbols - heartbeat 186s ago
· 2026-10-08 08:05
Pre-market
36.98
+2.35%
After-hours
36.13
0.00%
- Market cap
- 4.26B
- P/E (TTM)i
- 12.95
- P/Bi
- -20.60
- EPSi
- 1.64
- Div yieldi
- 0.00%
- 52W posi
- 65%
Reader sentiment
Are you bullish or bearish on INDV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.18, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.29% YoY
Margins
- Gross margin
- 80.15%
- Operating margin
- 21.39%
- Net margin
- 16.95%
Key ratios & quality
- Enterprise valuei
- 4.40B
- Altman Z-Scorei
- 3.18
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.01B | 785.00M | 647.00M | 791.00M | 901.00M | 1.09B | 1.19B | 1.24B |
| Gross profit | 877.00M | 645.00M | 550.00M | 664.00M | 750.00M | 919.00M | 957.00M | 993.00M |
| Selling & admin expenses | 481.00M | 395.00M | 649.00M | 431.00M | 469.00M | 565.00M | 612.00M | 634.00M |
| Research & development | 67.00M | 53.00M | 40.00M | 52.00M | 74.00M | 116.00M | 107.00M | 97.00M |
| Operating profit | 316.00M | 178.00M | -156.00M | 181.00M | 215.00M | 247.00M | 234.00M | 265.00M |
| Pretax profit | 278.00M | 180.00M | -173.00M | 190.00M | -89.00M | -145.00M | 20.00M | 239.00M |
| Tax | 3.00M | 46.00M | -25.00M | -15.00M | -44.00M | -19.00M | 13.00M | 29.00M |
| Net profit | 275.00M | 134.00M | -148.00M | 205.00M | -45.00M | -126.00M | 7.00M | 210.00M |
| Basic EPS | 2 | 1 | -1 | 1 | 0 | -1 | 0 | 2 |
| Diluted EPS | 1.85 | 0.90 | -1.00 | 1.35 | -0.32 | -0.92 | 0.05 | 1.64 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 266.00M | 302.00M | 314.00M | 358.00M | 317.00M | 343.00M |
| Gross profit | 222.00M | 250.00M | 231.00M | 291.00M | 277.00M | 293.00M |
| Selling & admin expenses | 133.00M | 158.00M | 155.00M | 189.00M | 124.00M | 122.00M |
| Research & development | 22.00M | 21.00M | 33.00M | 21.00M | 16.00M | 12.00M |
| Operating profit | 67.00M | 71.00M | 44.00M | 83.00M | 137.00M | 159.00M |
| Pretax profit | 59.00M | 62.00M | 37.00M | 81.00M | 115.00M | 160.00M |
| Tax | 11.00M | 44.00M | -5.00M | -21.00M | 26.00M | 38.00M |
| Net profit | 48.00M | 18.00M | 42.00M | 102.00M | 89.00M | 122.00M |
| Basic EPS | 0 | 0 | 0 | 1 | 1 | 1 |
| Diluted EPS | 0.38 | 0.14 | 0.33 | 0.79 | 0.69 | 0.98 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.33B | 1.36B | 1.19B | 1.44B | 1.26B | 1.27B | 827.00M | 652.00M |
| Cash & ST investments | 924.00M | 1.06B | 858.00M | 1.10B | 893.00M | 410.00M | 320.00M | 195.00M |
| Inventory | 78.00M | 73.00M | 93.00M | 95.00M | 114.00M | 135.00M | 178.00M | 155.00M |
| Total assets | 1.55B | 1.65B | 1.53B | 1.83B | 1.77B | 1.76B | 1.32B | 1.20B |
| Total current liabilities | 818.00M | 742.00M | 599.00M | 804.00M | 1.02B | 1.29B | 924.00M | 914.00M |
| Short-term debt | 4.00M | 9.00M | 12.00M | 11.00M | 11.00M | 12.00M | 28.00M | 39.00M |
| Long-term debt | 237.00M | 233.00M | 230.00M | 239.00M | 237.00M | 237.00M | 315.00M | 290.00M |
| Total liabilities | 1,481,000,000.00 | 1,443,000,000.00 | 1,449,000,000.00 | 1,629,000,000.00 | 1,718,000,000.00 | 1,952,000,000.00 | 1,653,000,000.00 | 1,300,000,000.00 |
| Total equity | 66.00M | 209.00M | 82.00M | 203.00M | 51.00M | -192.00M | -337.00M | -99.00M |
| Retained earnings | 1.32B | 1.45B | 1.31B | 1.44B | 1.30B | -295.00M | -443.00M | -243.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 883.00M | 951.00M | 922.00M | 652.00M | 667.00M | 725.00M |
| Cash & ST investments | 373.00M | 510.00M | 445.00M | 195.00M | 175.00M | 222.00M |
| Inventory | 163.00M | 149.00M | 157.00M | 155.00M | 152.00M | 151.00M |
| Total assets | 1.38B | 1.45B | 1.42B | 1.20B | 1.20B | 1.23B |
| Total current liabilities | 1.01B | 1.06B | 965.00M | 914.00M | 779.00M | 868.00M |
| Short-term debt | 29.00M | 29.00M | 28.00M | 39.00M | 9.00M | 9.00M |
| Long-term debt | 311.00M | 308.00M | 304.00M | 290.00M | 486.00M | 487.00M |
| Total liabilities | 1,661,000,000.00 | 1,710,000,000.00 | 1,623,000,000.00 | 1,300,000,000.00 | 1,341,000,000.00 | 1,440,000,000.00 |
| Total equity | -286.00M | -258.00M | -207.00M | -99.00M | -144.00M | -207.00M |
| Retained earnings | -406.00M | -388.00M | -346.00M | -243.00M | -280.00M | -334.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 303.00M | 151.00M | -193.00M | 353.00M | -4.00M | -300.00M | 36.00M | -27.00M |
| Depreciation & amortization | 16.00M | 28.00M | 26.00M | 22.00M | 16.00M | 15.00M | 28.00M | 20.00M |
| Free cash flow | 262.00M | 144.00M | -197.00M | 319.00M | -9.00M | -353.00M | 5.00M | -94.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 3.00M | 0 | 1.00M | -100.00M | -88.00M | -30.00M | -170.00M | -9.00M |
| Ending cash balance | 924.00M | 1.06B | 858.00M | 1.10B | 774.00M | 316.00M | 319.00M | 195.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 75.00M | 158.00M | -39.00M | -221.00M | -9.00M | 229.00M |
| Depreciation & amortization | 5.00M | 5.00M | 5.00M | 5.00M | 4.00M | 3.00M |
| Free cash flow | 70.00M | 140.00M | -59.00M | -245.00M | -29.00M | 222.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -10.00M | -1.00M | 2.00M | 0 | -126.00M | -176.00M |
| Ending cash balance | 372.00M | 510.00M | 445.00M | 195.00M | 175.00M | 222.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | 97.45 | -101.72 | 143.86 | -41.73 | 7.84 | -- | -- |
| ROA %i | 18.39 | 8.38 | -9.30 | 12.19 | -2.94 | 0.11 | 0.12 | 16.67 |
| ROIC %i | -- | 32.39 | -30.71 | 52.16 | -10.98 | -0.80 | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 30.45 | 25.48 | -23.03 | 27.31 | -7.33 | 3.48 | 4.63 | 22.92 |
| FCF / sales %i | 26.07 | 18.34 | -- | 40.33 | -- | -- | 0.42 | -- |
| Current ratioi | 1.62 | 1.83 | 1.98 | 1.80 | 1.24 | 0.98 | 0.90 | 0.71 |
| Quick ratioi | 1.52 | 1.69 | 1.74 | 1.64 | 1.10 | 0.51 | 0.66 | 0.49 |
| Debt / assetsi | 15.58 | 17.74 | 18.62 | 15.61 | 15.66 | 16.08 | 28.50 | 29.23 |
| LT debt / equityi | 359.09 | 135.89 | 332.93 | 135.47 | 521.57 | -- | -- | -- |
| Interest coveragei | 10.93 | 10.00 | -6.21 | 8.31 | -2.28 | 1.03 | 1.34 | 6.31 |
| Revenue CAGR (3Y) %i | -0.30 | -9.47 | -16.04 | -7.67 | 4.70 | 19.10 | 14.52 | 11.20 |
| Net income CAGR (3Y) %i | 6.45 | 56.44 | -- | -9.33 | -- | -- | -67.56 | -- |
| FCF CAGR (3Y) %i | -3.22 | -27.12 | -- | 6.78 | -- | -- | -74.97 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -0.85 | 6.90 | 8.61 | 16.67 | 19.60 | 26.52 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.76 | 19.86 | 20.51 | 22.92 | 25.97 | 31.63 |
| FCF / sales %i | 9.83 | 14.58 | 9.92 | -- | -- | -- |
| Current ratioi | 0.88 | 0.90 | 0.96 | 0.71 | 0.86 | 0.84 |
| Quick ratioi | 0.64 | 0.71 | 0.74 | 0.49 | 0.59 | 0.59 |
| Debt / assetsi | 26.91 | 25.21 | 25.14 | 29.23 | 42.52 | 41.28 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 1.00 | 4.66 | 4.65 | 6.31 | 8.38 | 15.59 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Sublocade is the largest reported line at 69.39% of revenue, across 4 reported segments.
- Sublingual & other follows at 16.62%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Sublocade69.39%
Sublingual & other16.62%
Rest of world12.54%
Perseris1.46%
Quote time 2026-10-08 08:05:55 · For reference only, not investment advice and not tailored to your situation.